Bifunctional Therapeutic Peptide Assembled Nanoparticles Exerting Improved Activities of Tumor Vessel Normalization and Immune Checkpoint Inhibition

Area of Science:

• Biomedical Engineering
• Nanomedicine
• Cancer Research

Background:

• Tumor immunotherapy effectiveness is limited by abnormal tumor vasculature, causing hypoxia and immune cell exclusion.
• Vascular normalization improves drug delivery and immune cell infiltration, crucial for effective anti-cancer immunity.

Purpose of the Study:

• To design and characterize a novel peptide amphiphile nanoparticle for simultaneous tumor vascular normalization and immune checkpoint blockade.
• To investigate the synergistic effect of dual-action nanomedicine on tumor suppression.

Main Methods:

• Synthesized and characterized peptide amphiphile nanoparticles incorporating an antiangiogenic peptide (FSEC) and an immune checkpoint inhibitor (D PPA).
• Evaluated the nanoparticle's ability to normalize tumor vasculature and enhance anti-tumor T cell infiltration in vivo.
• Assessed the impact of combined vascular normalization and PD-1/PD-L1 pathway blockade on tumor suppression.

Main Results:

• The peptide amphiphile nanoparticle demonstrated successful normalization of tumor vasculature.
• Vascular normalization led to increased intratumoral infiltration of immune cells.
• Simultaneous blockade of the PD-1/PD-L1 pathway reactivated anti-tumor immune responses, resulting in synergistic tumor suppression.

Conclusions:

• Simultaneous modulation of tumor vasculature and the immune system using functional peptide nanoparticles offers a promising nanomedicine strategy for cancer therapy.
• This approach provides a new perspective on regulating tumor vessel normalization and enhancing immunotherapy efficacy.
• The developed nanomedicine holds potential for improved therapeutic outcomes in cancer treatment.